GLP-1 receptor agonists mimic a hormone that helps regulate appetite, insulin secretion, and gastric emptying. Medications in this class have become widely discussed for weight management because they can reduce hunger and support more sustainable calorie control when paired with lifestyle guidance.
Tirzepatide and semaglutide are two commonly prescribed options, each with distinct dosing schedules, monitoring needs, and side-effect profiles. Nausea, GI upset, and hydration shifts are frequent talking points in early weeks of therapy. A licensed clinician can help titrate thoughtfully and screen for contraindications.
These medications are not cosmetic shortcuts. They work best as part of a broader metabolic plan that includes protein targets, resistance training, sleep, and follow-up labs where appropriate. Candidates often include adults with obesity or overweight with weight-related conditions—though individual eligibility always depends on medical history.
If you are evaluating GLP-1 therapy, prioritize a telehealth or in-person visit that reviews your medications, family history, and goals. Altara Health focuses on accessible, clinician-led care so you can make informed decisions with professional oversight.
